Drug intelligence / Profile preview

Fuyanting

Development stage
Phase 2
Lead developer
Guilin Sanjin Pharmaceutical
Modality
Small Molecules
Administration
Vaginal, Oral
01

Overview

Fuyanting is a proprietary Traditional Chinese Medicine (TCM) product developed by Guilin Sanjin Pharmaceutical Co., Ltd., primarily indicated for the treatment of gynecological infections including bacterial vaginosis, trichomonal vaginitis, and vulvovaginal candidiasis. The formulation is available in several dosage forms, most notably as effervescent tablets for vaginal administration and capsules for oral use. It is composed of multiple herbal extracts, including *Sophora flavescens* (Kushen), *Phellodendron chinense* (Huangbai), *Cnidium monnieri* (Shechuangzi), and *Atractylodes lancea* (Cangzhu), along with mineral components like alum. These ingredients contain active alkaloids such as matrine and berberine, which provide broad-spectrum antimicrobial, antifungal, and anti-inflammatory activities. Fuyanting works by inhibiting the growth of pathogenic microorganisms and modulating the local inflammatory response, thereby restoring the normal vaginal microenvironment.

Brand names
FuyantingFuyanting Effervescent TabletsFuyanting Capsules
Other names
妇炎婷Fuyanting Paoteng Pian
02

Targets

DNAIL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Fuyanting.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuyanting.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call